ACAD Competitors & Alternatives
Compare ACADIA Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ACAD
Main Stock$20.69
Tradestie Score
51
Market Cap
$3.58B
P/E Ratio
9.7
Revenue Growth
0.1%
Analyst Upside
+53.0%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$100.74
|
$3.98B | - | 65 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$34.70
|
$3.92B | - | 57 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$79.67
|
$3.91B | - | 57 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$18.86
|
$3.83B | - | 53 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$18.56
|
$3.68B | - | 50 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$95.49
|
$3.67B | - | 53 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.38
|
$3.59B | 12.2 | 51 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$207.89
|
$3.49B | 27.8 | 58 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.28
|
$3.40B | - | 54 | Compare |
|
QURE
uniQure N.V.
|
$24.93
|
$3.39B | - | 61 | Compare |
More ACAD Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry